FAQ

Medical device brands going global: how to win AI search visibility

Buyers ask AI before they talk procurement. The four point losses medical device brands suffer most, and the three fixes to make first: registration facts in page text, locked model naming, citable clinical evidence.

Figure 01 · Three layers of device fact pages: registration, evidence, entity

  1. 01

    Layer 1: Registration-and-specs page

    Registration status, certificate details and scope listed by market; HTML text + structured data; scanned certificates as attachments only.

    Boundary: no blanket claims like “internationally certified” that cannot be verified.
  2. 02

    Layer 2: Clinical evidence summary page

    One page per key study — design, population, endpoints, conclusions, with the journal source credited.

    Boundary: state only what the study itself concluded — never stitch conclusions across studies.
  3. 03

    Layer 3: Entity and model mapping

    Brand name, registration holder and model mapping per market, identical everywhere; OEM versus own-brand stated in one disambiguating line.

    Boundary: where the registration holder differs by market, state it market by market — never merge.
Approved claims stay in their market: never write market A's indications into market B's section. The three fact-page layers and what each carries. Official explainers for the EU Medical Device Regulation (MDR) and the FDA premarket notification (510(k)) are listed under Sources; measured data: Negency Flagship Report 2026 (Issue 1) (one of the top five scorers is Mindray, mindray.com, 92).

For medical devices, AI visibility is a compliance question first

For a medical device brand, a wrong AI answer is not just a lost deal: a wrong spec is a bad citation for a consumer brand, but claiming approval in a market where you have none is a compliance incident. Overseas distributors, hospital buyers and clinical departments now ask ChatGPT, Perplexity and Gemini before they ever talk to sales — "which patient monitors fit a community hospital?", "is this Chinese manufacturer's device registered in the EU?", "who in this category has clinical data?". If AI's answer names you, there is a registration check and a deal to win; if it garbles your registration status, merges you with an OEM namesake, or never mentions you, you are out. This page covers the four most common point losses and the three fixes to make first — ordered by compliance risk.

Registration and certification: stated market by market

Registration status, certificate numbers and scope sit inside scanned PDF certificates, market by market. Crawlers cannot read them, so AI assembles answers from distributor pages and trade-show catalogues instead. The fix: give every hero product a crawlable registration-and-specs page — status, certificate details and scope by market, in HTML text with structured data. Scanned certificates belong as attachments, not as the only carrier. In the EU, devices fall under the Medical Device Regulation (MDR); in the US, the premarket notification (510(k)) route is one FDA pathway — state which route and status actually apply in each market, not blanket claims such as "internationally certified".

Clinical evidence: turn it into citable summaries

Clinical studies are this industry's strongest third-party proof — but if they live only in journal databases and PDFs while your own site carries marketing copy, AI cites competitors' evidence summaries, not yours. The fix: one page per key study — design, population, endpoints and conclusions in page text, journal source credited. For example, a monitor's summary page stating study population, control setup, endpoints and conclusions, with the journal named, gives AI a page of yours to cite when buyers ask "who in this category has clinical data".

Models, registration holders and OEM lines

One device, different registration holders, model names and OEM arrangements per market. AI cannot confirm they are one product line, and recommends the competitor whose registration facts are cleaner. Keep brand name, registration holder and model mapping for each market identical, word for word, across site, directories and press releases, with one disambiguating line where OEM and own-brand lines coexist.

Approved claims must not bleed across markets

Indications, target populations and limitations are approved market by market, and AI readily applies one market's claims to another; the English site usually carries far less than the Chinese one, while overseas buyers ask in English. State each market's claims only in that market's section, labelled accordingly, and keep the English registration-and-specs pages in item-by-item correspondence with the Chinese ones — no "English version is slogans only" gap. For managing language versions, see the multilingual website guide.

Measured: done right, this category reaches the top

In our measurement of 30 global-facing websites of Chinese exporters (Negency Flagship Report 2026, Issue 1, sampled on a single day, 30 October 2026; technical website visibility only, not brand mention rates in AI answers), one of the top five scorers is a medical device company, Mindray (mindray.com, 92 out of 100). A compliance-heavy category can reach the top — if registration and evidence facts are machine-readable pages.

Fix these three first

  1. Move registration and specs into page text. One registration-and-specs page per hero product: status, certificate details and scope by market, in HTML with structured data.
  2. Lock the entity and model facts. Brand name, registration holder and model mapping per market identical everywhere; one line disambiguating OEM versus own-brand lines.
  3. Turn clinical evidence into citable summary pages. One page per key study: design, population, endpoints, conclusions, journal source credited.

What to watch when you resample

Ask the major AI engines a fixed set of buyer questions on a regular cycle, and track mention rate, citation sources and the accuracy of compliance statements — for devices, watch registration status above all. If a registration status is stated wrongly, follow the four-step framework in AI is saying wrong things about our company: document and trace first, then fix the source. No baseline, no optimisation. Start with our free AI visibility audit for your three scores in minutes; for the full competitor comparison and fix list, see the AI search visibility diagnostic package. For a systematic pre-launch check, use the AI search visibility checklist; a neighbouring hardware category: consumer electronics.

Related questions

How is GEO different from SEO?

SEO optimises a page's rank in a list of links, aiming for clicks. GEO (Generative Engine Optimization) optimises how discoverable, understandable, trustworthy and citable a company is inside AI-generated answers — the goal is to be in the answer itself. They share technical foundations (crawlability, structured data, content quality), but GEO additionally requires governed entity facts, a machine-readable surface (llms.txt, Markdown mirrors) and a third-party mention ecosystem. A site that ranks well is not automatically visible to AI: engines cite the companies whose facts they can fetch, parse and verify. The concrete differences sit in four dimensions — goal, object, content structure and evaluation — compared item by item in the body below.

How can Chinese companies going global build AI search visibility?

For Chinese companies going global, the visibility gap is rarely content volume — it is the machine-readable surface. Our audit of 30 Chinese outbound companies found machine-readability the weakest category (69.2/100 average): 17 had no JSON-LD on the homepage, 15 had a missing or thin sitemap, 13 had a missing or duplicated H1. The path has four steps: audit bot reachability and machine-readability first; govern entity facts so Chinese and English statements agree; publish question-shaped content built on real overseas buyer questions; then earn third-party mentions (media, communities, partners) and verify with periodic resampling against a fixed question set.

What should a corporate website change for the AI search era?

Five changes. (1) Bot reachability: robots.txt explicitly allows AI crawlers and live fetches are not stopped by firewalls or challenge pages. (2) A machine-readable surface: an llms.txt fact file (optional aid), a complete sitemap, Markdown versions of core pages (optional). (3) Entity structure: JSON-LD naming entity types such as Organization, clean title/H1 discipline, hreflang pairing on bilingual sites. (4) Question-shaped content: pages organised around buyer questions, short answers first, FAQ schema attached. (5) Measurability: analytics that separate human and bot traffic and attribute AI-referred inquiries. Negency's own site was rebuilt to exactly this standard, and the public audit tool scores against it.

What is llms.txt, and should every company website have one?

llms.txt is a plain-text brief at the site root written for AI systems: who the company is, what it does, where the core pages live, and the canonical facts and definitions. It does not by itself raise citation rates — in Ahrefs' May 2026 study of 137,210 domains, 97% of published llms.txt files received zero requests that month, so its direct effect is near zero — but it is the cheapest fact-governance move available: one file anchors a single version of the truth that crawlers can rely on. Verdict: worth adding, useless alone; it works as part of entity-fact governance, structured data and question-shaped content. Negency's llms.txt is a full fact bible: company definition, offering boundaries, sourced cases and citation rules.

What should an enterprise prepare before deploying AI agents?

Four preparations, and we advise against starting without any of them. (1) Scenario selection: pilot on a workflow that is frequent, comparatively rule-clear and verifiable — not the most glamorous one. (2) Knowledge and data foundations: govern the knowledge base first (deduplication, versioning, permissions); a dirty knowledge base only scales errors. (3) Governance design: permission boundaries, human approval points and audit logs decided before launch, not after. (4) A measurement baseline: record the manual process's time and error rates before the pilot, or value can never be proven afterwards. Negency's method is a small controlled pilot, verified before scaling, with governance as a design input rather than a patch.